Patients with tattoos aged 20 to 60 years are at a greater risk of developing cutaneous melanoma than matched control patients without tattoos.

In the pivotal clinical trial of their technology, researchers at Orlucent®, Inc. have confirmed the accuracy of the company's Skin Fluorescent Imaging (SFI) System, a non-invasive, hand-held ...

Researchers found better detection, treatment and decreased smoking have been immensely helpful in reducing deaths due to cancer.

A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

In patients with high-risk melanoma, the personalized cancer vaccine intismeran autogene and Keytruda reduced the risk of ...

By Kamal Choudhury and Mariam Sunny Jan 20 (Reuters) - Moderna and Merck said on Tuesday their experimental personalized ...

Intismeran autogene with pembrolizumab shows a 49% reduction in recurrence or death risk in high-risk resected melanoma ...

A diagnosis of uveal melanoma marks the beginning of a long-term relationship with your medical team. While the focus starts ...

After first being diagnosed with stage 2 melanoma in 2022, her cancer progressed to stage 4 in 2025 ...

During a live event, Omid Hamid, MD, discussed the logistics and multidisciplinary process of using tumor-infiltrating ...

Melanoma, known for its aggressiveness and high mutational burden, presents itself as a prime candidate for neoantigen-targeted immunotherapies. Although ...

Regulatory deregulation and liquid biopsy adoption pushing the rapid growth of the oncology companion diagnostic market. In ...